SCHEMBL3792291

SCHEMBL3792291

O=C(O)c1nc(F)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CTSA P10619 1/20 0.41
KDM4E B2RXH2 7/20 0.39
ASPH Q12797 1/20 0.39
KDM8 Q8N371 1/20 0.39
CYP1A2 P05177 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
CYP2C9 P11712 1/20 0.35
KMO O15229 3/20 0.35
ALOX15 P16050 2/20 0.34
TSHR P16473 2/20 0.34
ACMSD Q8TDX5 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALB P02768 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23631777 0.84 CTSA (0.37) ALDH1A1MAPTSMN1; SMN2CTSAKDM4E
SCHEMBL15441401 0.82 CTSA (0.38) CTSA
SCHEMBL31645569 0.82 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2KDM4EASPH
SCHEMBL18784185 0.80 CTSA (0.38) CTSA
SCHEMBL18817829 0.80 CTSA (0.38) CTSAKEAP1NFE2L2KMO
SCHEMBL23631780 0.80 IDO1 (0.41) MAPTCTSAMEN1KMT2A
SCHEMBL18498680 0.80 CTSA (0.40) SMN1; SMN2CTSAMEN1KMT2AL3MBTL1
SCHEMBL18784144 0.80 ALDH1A1 (0.39) ALDH1A1CTSAKEAP1NFE2L2ALOX15
SCHEMBL8666506 0.80 KDM4E (0.47) ALDH1A1MAPTSMN1; SMN2KDM4EASPH
SCHEMBL1780517 0.78 MEN1 (0.44) ALDH1A1MAPTSMN1; SMN2KDM4EASPH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 EP claimed
US-20240011009-A1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS Encodia, Inc. (US) 2024-01-11 US claimed
US-20230220589-A1 POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF Encodia, Inc. (US) 2023-07-13 US claimed
EP-4127157-A1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS Encodia, Inc. (US) 2023-02-08 EP claimed
WO-2022072560-A1 POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF Encodia, Inc. (US) 2022-04-07 WO claimed
WO-2021194908-A1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS Encodia, Inc. (US) 2021-09-30 WO claimed
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 EP disclosed
US-20250340574-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2025-11-06 US disclosed
CN-117242067-B Novel aryl ether substituted heterocycles as GLP1R agonists 杭州德睿智药科技有限公司 2025-03-25 CN disclosed
EP-3253757-B1 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2025-03-19 EP disclosed
EP-4504739-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2025-02-12 EP disclosed
CN-118955472-A 2- (Hetero) aryl substituted fused heterocyclic derivatives as pesticides 拜耳作物科学股份公司 2024-11-15 CN disclosed
US-20240294533-A1 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2024-09-05 US disclosed
EP-2112994-B1 ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES BASF SE (DE) 2011-01-26 EP disclosed
WO-2010135579-A1 FLUORINATED DIARYL UREA DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2010-11-25 WO disclosed
US-20100108994-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES UDC IRELAND LIMITED (IE) 2010-05-06 US disclosed
WO-2010031738-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH AZAPYRENES BASF SE (DE) 2010-03-25 WO disclosed
WO-2009100991-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES BASF SE (DE) 2009-08-20 WO disclosed
EP-2080796-A1 Electroluminescent metal complexes with nucleophilic carbene ligands Ciba Holding Inc. (CH) 2009-07-22 EP disclosed
WO-2008101842-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES BASF SE (CH) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108994-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES OCIAD1, OCIAD2, OXA1L ALDH1A1 320/4885MAPT 388/4885SMN1; SMN2 3856/4885
US-20250340574-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B ALDH1A1 3983/4885MAPT 4870/4885SMN1; SMN2 4787/4885
US-20240294533-A1 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS CYP8B1, CYP4X1, HRH2 ALDH1A1 787/4885MAPT 4782/4885SMN1; SMN2 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.